These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Improved lentiviral vectors for Wiskott-Aldrich syndrome gene therapy mimic endogenous expression profiles throughout haematopoiesis. Frecha C, Toscano MG, Costa C, Saez-Lara MJ, Cosset FL, Verhoeyen E, Martin F. Gene Ther; 2008 Jun; 15(12):930-41. PubMed ID: 18323794 [Abstract] [Full Text] [Related]
3. A lentiviral vector encoding the human Wiskott-Aldrich syndrome protein corrects immune and cytoskeletal defects in WASP knockout mice. Charrier S, Stockholm D, Seye K, Opolon P, Taveau M, Gross DA, Bucher-Laurent S, Delenda C, Vainchenker W, Danos O, Galy A. Gene Ther; 2005 Apr; 12(7):597-606. PubMed ID: 15616597 [Abstract] [Full Text] [Related]
9. Expression of human Wiskott-Aldrich syndrome protein in patients' cells leads to partial correction of a phenotypic abnormality of cell surface glycoproteins. Huang MM, Tsuboi S, Wong A, Yu XJ, Oh-Eda M, Derry JM, Francke U, Fukuda M, Weinberg KI, Kohn DB. Gene Ther; 2000 Feb; 7(4):314-20. PubMed ID: 10694812 [Abstract] [Full Text] [Related]
10. Optimization of adenovirus serotype 35 vectors for efficient transduction in human hematopoietic progenitors: comparison of promoter activities. Sakurai F, Kawabata K, Yamaguchi T, Hayakawa T, Mizuguchi H. Gene Ther; 2005 Oct; 12(19):1424-33. PubMed ID: 15944730 [Abstract] [Full Text] [Related]
11. Validation of a mutated PRE sequence allowing high and sustained transgene expression while abrogating WHV-X protein synthesis: application to the gene therapy of WAS. Zanta-Boussif MA, Charrier S, Brice-Ouzet A, Martin S, Opolon P, Thrasher AJ, Hope TJ, Galy A. Gene Ther; 2009 May; 16(5):605-19. PubMed ID: 19262615 [Abstract] [Full Text] [Related]
12. Gene therapy for Wiskott-Aldrich syndrome--long-term efficacy and genotoxicity. Braun CJ, Boztug K, Paruzynski A, Witzel M, Schwarzer A, Rothe M, Modlich U, Beier R, Göhring G, Steinemann D, Fronza R, Ball CR, Haemmerle R, Naundorf S, Kühlcke K, Rose M, Fraser C, Mathias L, Ferrari R, Abboud MR, Al-Herz W, Kondratenko I, Maródi L, Glimm H, Schlegelberger B, Schambach A, Albert MH, Schmidt M, von Kalle C, Klein C. Sci Transl Med; 2014 Mar 12; 6(227):227ra33. PubMed ID: 24622513 [Abstract] [Full Text] [Related]
13. Lentiviral vectors transcriptionally targeted to hematopoietic cells by WASP gene proximal promoter sequences. Martín F, Toscano MG, Blundell M, Frecha C, Srivastava GK, Santamaría M, Thrasher AJ, Molina IJ. Gene Ther; 2005 Apr 12; 12(8):715-23. PubMed ID: 15750617 [Abstract] [Full Text] [Related]
20. Efficient transcriptional targeting of human hematopoietic stem cells and blood cell lineages by lentiviral vectors containing the regulatory element of the Wiskott-Aldrich syndrome gene. Leuci V, Gammaitoni L, Capellero S, Sangiolo D, Mesuraca M, Bond HM, Migliardi G, Cammarata C, Aglietta M, Morrone G, Piacibello W. Stem Cells; 2009 Nov 10; 27(11):2815-23. PubMed ID: 19785032 [Abstract] [Full Text] [Related] Page: [Next] [New Search]